We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
-5.85%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$35.2B
AUM Growth
-$3.94B
(-10%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$63.8M |
| 2 |
Align Technology
ALGN
|
+$61.4M |
| 3 |
Stellantis
STLA
|
+$54.4M |
| 4 |
UBS Group
UBS
|
+$49.7M |
| 5 |
Republic Services
RSG
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$73.1M |
| 2 |
IPG Photonics
IPGP
|
+$62.1M |
| 3 |
Adobe
ADBE
|
+$61.1M |
| 4 |
UnitedHealth
UNH
|
+$56.3M |
| 5 |
Apple
AAPL
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.86% |
| 2 | Healthcare | 17.08% |
| 3 | Financials | 11.33% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Deckers Outdoor
DECK
$10.6B
| $12.7M | 0.04% |
277,746
-29,472
| -10% | -$1.46M |
|
|
SLN
427
Silence Therapeutics
SLN
$774M
| $12.6M | 0.04% |
661,666
| – | – |
|
428
Southern Company
SO
$98.9B
| $12.5M | 0.04% |
172,511
-37,320
| -18% | -$2.53M |
|
429
SLB Ltd
SLB
$80.4B
| $12.4M | 0.04% |
328,868
+192,557
| +141% | +$7.55M |
|
430
Incyte
INCY
$24.7B
| $12.4M | 0.04% |
155,856
-245,164
| -61% | -$17.8M |
|
431
OneSpaWorld
OSW
$2.2B
| $12.4M | 0.04% |
1,210,959
+256,830
| +27% | +$2.62M |
|
432
Sea Limited
SE
$62.9B
| $12.3M | 0.04% |
102,686
+27,914
| +37% | +$3.93M |
|
433
Molina Healthcare
MOH
$10.8B
| $12.2M | 0.03% |
36,626
+34,500
| +1,623% | +$10.6M |
|
434
Americold
COLD
$4.28B
| $12.1M | 0.03% |
434,641
+26,300
| +6% | +$739K |
|
435
Regal Rexnord
RRX
$10.2B
| $12M | 0.03% |
80,900
-5,700
| -7% | -$914K |
|
436
Bright Horizons
BFAM
$3.28B
| $12M | 0.03% |
90,137
-11,498
| -11% | -$1.49M |
|
437
VICI Properties
VICI
$27.3B
| $12M | 0.03% |
420,050
-800
| -0.2% | -$22.4K |
|
438
Exelixis
EXEL
$14.1B
| $11.8M | 0.03% |
521,502
+5
| +0% | +$98 |
|
439
Raymond James Financial
RJF
$32.5B
| $11.8M | 0.03% |
107,039
+102,468
| +2,242% | +$10.9M |
|
440
Saia
SAIA
$9.41B
| $11.7M | 0.03% |
48,000
-2,400
| -5% | -$665K |
|
|
AMED
441
DELISTED
Amedisys
AMED
| $11.7M | 0.03% |
67,704
-3,396
| -5% | -$507K |
|
442
Clorox
CLX
$10.5B
| $11.7M | 0.03% |
83,872
+4,300
| +5% | +$659K |
|
443
Sun Life Financial
SLF
$44.8B
| $11.6M | 0.03% |
207,991
+60,512
| +41% | +$3.33M |
|
444
Popular Inc
BPOP
$10.5B
| $11.6M | 0.03% |
141,800
+62,500
| +79% | +$5.52M |
|
445
Aflac
AFL
$58.9B
| $11.5M | 0.03% |
178,515
+72,388
| +68% | +$4.53M |
|
446
Otis Worldwide
OTIS
$26.1B
| $11.4M | 0.03% |
148,116
-41,539
| -22% | -$3.32M |
|
447
International Flavors & Fragrances
IFF
$21.5B
| $11.4M | 0.03% |
86,726
+239
| +0.3% | +$31.7K |
|
448
Fidelity National Financial
FNF
$11.7B
| $11.3M | 0.03% |
241,594
+62,168
| +35% | +$2.97M |
|
449
Akamai
AKAM
$15.1B
| $11.2M | 0.03% |
93,850
+1,553
| +2% | +$174K |
|
450
Exponent
EXPO
$3.2B
| $11.1M | 0.03% |
102,901
| – | – |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2022 Portfolio in Review
As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Freshpet worth $30.3M.
- Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
- Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
- Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
- Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
- Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
- Axa opened 111 new positions and closed 94 in Q1 2022.
- Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.
Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.